Oncotarget

Corrections:

Correction: γKlotho is a novel marker and cell survival factor in a subset of triple negative breast cancers

PDF  |  How to cite

Oncotarget. 2019; 10:916-916. https://doi.org/10.18632/oncotarget.26649

Metrics: PDF 431 views  |   ?  

Nuša Trošt1,2, Samuel Peña-Llopis2, Sajjan Koirala3, Jurij Stojan1, Patrick Ryan Potts3, Klementina Fon Tacer3 and Elisabeth D. Martinez2,4

1 Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
2 Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas, USA
3 Department of Physiology, University of Texas Southwestern Medical Center, Dallas, Texas, USA
4 Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas, USA

Published: January 25, 2019

This article has been corrected: The correct Keywords are given below:

Keywords: LCTL; gamma Klotho; FGF; breast cancer; cancer therapy; ROS; oxidative stress; oncogene

Original article: Oncotarget. 2016; 7:2611-2628. DOI: https://doi.org/10.18632/oncotarget.6006.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 26649